Status:
COMPLETED
First in Human Study of NI-0701 in Healthy Volunteers
Lead Sponsor:
Light Chain Bioscience - Novimmune SA
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.
Eligibility Criteria
Inclusion
- Non smokers
- Able to adhere to study visits and protocol requirements
Exclusion
- Any clinical safety laboratory measurements value \> Grade 1 on WHO Toxicity Scale
- Established or recurrent history of allergic reactions
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01255501
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London, United Kingdom